AAAAAA

   
Results: 1-14 |
Results: 14
Analysis of the postprandial lipid metabolism: Use of a 3-point test
Authors: Guerci, B Paul, JL Hadjadj, S Durlach, V Verges, B Attia, N Girard-Globa, A Drouin, P
Citation: B. Guerci et al., Analysis of the postprandial lipid metabolism: Use of a 3-point test, DIABETE MET, 27(4), 2001, pp. 449-457
The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia.
Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Basal and postprandial serum-promoted cholesterol efflux in normolipidemicsubjects: Importance of fat mass distribution
Authors: Autran, D Guerci, B Paul, JL Moulin, P Verges, B Durlach, V Girard-Globa, A
Citation: D. Autran et al., Basal and postprandial serum-promoted cholesterol efflux in normolipidemicsubjects: Importance of fat mass distribution, METABOLISM, 50(11), 2001, pp. 1330-1335
Statins: intervention studies facts and perspectives
Authors: Durlach, V
Citation: V. Durlach, Statins: intervention studies facts and perspectives, ANN ENDOCR, 62(2), 2001, pp. 133-144
Plasma levels of tumor necrosis factor-alpha (TNF-alpha] are essentially dependent on visceral fat amount in type 2 diabetic patients
Authors: Bertin, E Nguyen, P Guenounou, M Durlach, V Potron, G Leutenegger, M
Citation: E. Bertin et al., Plasma levels of tumor necrosis factor-alpha (TNF-alpha] are essentially dependent on visceral fat amount in type 2 diabetic patients, DIABETE MET, 26(3), 2000, pp. 178-182
Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients
Authors: Guerci, B Verges, B Durlach, V Hadjadj, S Drouin, P Paul, JL
Citation: B. Guerci et al., Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients, INT J OBES, 24(4), 2000, pp. 468-478
Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment
Authors: Autran, D Attia, N Dedecjus, M Durlach, V Girard-Globa, A
Citation: D. Autran et al., Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment, ATHEROSCLER, 153(2), 2000, pp. 453-460
Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment
Authors: Attia, N Durlach, V Cambilleau, M Roche, D Girard-Globa, A
Citation: N. Attia et al., Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment, ATHEROSCLER, 149(2), 2000, pp. 427-433
Ethical concerns in the management of DNA banks
Authors: Moutel, G de Montgolfier, S Corviole, K Gaillard, M Durlach, V Leutenegger, M Adnet, JJ Herve, C
Citation: G. Moutel et al., Ethical concerns in the management of DNA banks, PRESSE MED, 28(3), 1999, pp. 135-139
Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin - A study with individual plasmas presenting natural variations of Lp(a)
Authors: Soulat, T Loyau, S Baudouin, V Durlach, V Gillery, P Garnotel, R Loirat, C Angles-Cano, E
Citation: T. Soulat et al., Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin - A study with individual plasmas presenting natural variations of Lp(a), THROMB HAEM, 82(1), 1999, pp. 121-127
Delayed changes in postprandial lipid in young normolipidemic men after a nocturnal vitamin A oral fat load test
Authors: Hadjadj, S Paul, JL Meyer, L Durlach, V Verges, B Ziegler, O Drouin, P Guerci, B
Citation: S. Hadjadj et al., Delayed changes in postprandial lipid in young normolipidemic men after a nocturnal vitamin A oral fat load test, J NUTR, 129(9), 1999, pp. 1649-1655
Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascularpathology in type II diabetic patients
Authors: Durlach, A Clavel, C Girard-Globa, A Durlach, V
Citation: A. Durlach et al., Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascularpathology in type II diabetic patients, J CLIN END, 84(10), 1999, pp. 3656-3659
Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides
Authors: Guerci, B Antebi, H Meyer, L Durlach, V Ziegler, O Nicolas, JP Alcindor, LG Drouin, P
Citation: B. Guerci et al., Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides, CLIN CHEM, 45(9), 1999, pp. 1439-1448
Five years of DiabCare-France: assessement and perspectives.
Authors: Kleinebreil, L Durlach, V
Citation: L. Kleinebreil et V. Durlach, Five years of DiabCare-France: assessement and perspectives., DIABETE MET, 24, 1998, pp. 8-12
Risultati: 1-14 |